Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	115.85	71.48	487.73	343.26	219.7	287
Short-Term Investments	-	-	-	-	30.08	-
Trading Asset Securities	454.04	459.67	102.98	59.84	70.16	-
Cash & Short-Term Investments	569.89	531.15	590.72	403.11	319.94	287
Cash Growth	5.12%	-10.08%	46.54%	25.99%	11.48%	355.44%
Accounts Receivable	211.47	199.03	198.53	264	254.84	276.45
Other Receivables	20.43	15.36	11.75	22.23	39.61	34.13
Receivables	231.89	214.39	210.28	286.23	294.45	310.59
Inventory	1,605	1,626	1,617	1,603	1,597	1,616
Other Current Assets	7.53	3.75	13.32	10.17	10.53	10.01
Total Current Assets	2,415	2,376	2,431	2,303	2,222	2,223
Property, Plant & Equipment	425.6	450.34	483.66	526.11	501.49	423.3
Long-Term Investments	0.04	15.23	-	-	-	-
Goodwill	1.91	1.91	1.91	1.91	1.91	1.91
Other Intangible Assets	109.45	111.35	114.18	117.03	119.96	123.41
Long-Term Deferred Tax Assets	14.18	13.15	12.62	14.2	15.2	17.87
Long-Term Deferred Charges	1.67	2.15	2.02	3.07	2.99	4.1
Other Long-Term Assets	16.14	0.76	1.27	1.68	1.04	2.16
Total Assets	2,984	2,971	3,047	2,967	2,864	2,796
Accounts Payable	10.66	13	24.86	24.33	19.81	24.8
Accrued Expenses	5.24	22.26	32.51	30.68	48.11	20.58
Short-Term Debt	348.23	290.28	470.43	430.43	397.86	405.4
Current Portion of Long-Term Debt	4.02	0.42	-	-	2.55	10
Current Portion of Leases	-	2.98	2.34	3.29	3.31	-
Current Income Taxes Payable	11.86	0.01	2.78	0.64	5.55	3.09
Current Unearned Revenue	8.52	5.49	11.01	24.51	16.72	41.47
Other Current Liabilities	26.5	31.55	45.91	74.29	39.84	69.18
Total Current Liabilities	415.04	366	589.85	588.16	533.75	574.52
Long-Term Debt	129.7	149.7	-	-	-	2.55
Long-Term Leases	5.11	6.21	4.03	9.82	11.46	-
Long-Term Unearned Revenue	106.99	112.54	118.69	118.02	120.85	86.79
Long-Term Deferred Tax Liabilities	2.03	2.77	1.74	1.17	0.02	-
Total Liabilities	658.86	637.22	714.3	717.18	666.08	663.86
Common Stock	330.95	330.95	330.95	330.95	330.95	330.95
Additional Paid-In Capital	834.69	834.69	834.69	834.69	834.69	834.69
Retained Earnings	1,061	1,070	1,068	989.34	916.17	830.08
Total Common Equity	2,227	2,236	2,233	2,155	2,082	1,996
Minority Interest	98.12	97.83	99.26	94.45	116.47	136.52
Shareholders' Equity	2,325	2,333	2,332	2,249	2,198	2,132
Total Liabilities & Equity	2,984	2,971	3,047	2,967	2,864	2,796
Total Debt	487.07	449.59	476.8	443.55	415.18	417.95
Net Cash (Debt)	82.82	81.56	113.92	-40.44	-95.24	-130.96
Net Cash Growth	27.37%	-28.40%	-	-	-	-
Net Cash Per Share	0.25	0.25	0.34	-0.12	-0.29	-0.40
Filing Date Shares Outstanding	330.95	330.95	330.95	330.95	330.95	330.95
Total Common Shares Outstanding	330.95	330.95	330.95	330.95	330.95	330.95
Working Capital	2,000	2,010	1,841	1,714	1,688	1,649
Book Value Per Share	6.73	6.76	6.75	6.51	6.29	6.03
Tangible Book Value	2,115	2,122	2,117	2,036	1,960	1,870
Tangible Book Value Per Share	6.39	6.41	6.40	6.15	5.92	5.65
Buildings	-	548.14	548.14	545.7	400.71	400.4
Machinery	-	353.49	359	357.13	321.57	317.93
Construction In Progress	-	-	-	1.98	119.32	27.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.